Eye movement desensitization and processing for adolescents with major depressive disorder: study protocol for a...

Area of Science:

• Psychiatry
• Clinical Psychology
• Adolescent Mental Health

Background:

• Major Depressive Disorder (MDD) is prevalent in adolescents, with limited treatment efficacy and high relapse rates.
• Traumatic experiences are linked to MDD, yet trauma-focused treatments for adolescent MDD are understudied.
• Existing treatments for adolescent MDD have significant limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

• To evaluate the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy as a standalone intervention for adolescents diagnosed with MDD.
• To determine if EMDR can reduce depressive symptoms and meet criteria for MDD remission in an adolescent population.
• To explore the role of distressing/traumatic memories in the development and maintenance of adolescent MDD.

Main Methods:

• A randomized controlled trial comparing 6 sessions of EMDR therapy to a 6-week waiting list (WL) condition, followed by EMDR for the WL group.
• Inclusion criteria: 64 adolescents (aged 12-18) with DSM-5 diagnosed MDD and trauma-related memories.
• Primary outcomes: MDD classification criteria and depressive symptom levels. Secondary outcomes: PTSD, anxiety, and social-emotional problems. Baseline assessments included family functioning and abuse/neglect history.

Main Results:

• Primary outcome data on MDD remission rates and depressive symptom severity are pending.
• Secondary outcome data on PTSD, anxiety, and social-emotional problems are pending.
• Analysis of baseline factors like family functioning and history of abuse/neglect to predict treatment outcomes is ongoing.

Conclusions:

• EMDR therapy shows potential as a brief, trauma-focused intervention for adolescent MDD.
• Treating traumatic memories may be crucial for addressing the onset and maintenance of adolescent depression.
• Early intervention with EMDR for traumatic memories could prevent chronic or recurrent depressive disorders in adolescents.